ZAI Lab (Shanghai) Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2014-01-06
- Employees
- -
- Market Cap
- -
- Website
- http://www.zailaboratory.com
Clinical Trials
22
Active:3
Completed:9
Trial Phases
4 Phases
Phase 1:11
Phase 2:5
Phase 3:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Phase 1
11 (50.0%)Phase 2
5 (22.7%)Not Applicable
3 (13.6%)Phase 3
3 (13.6%)A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Not Applicable
Not yet recruiting
- Conditions
- Atopic Dermatitis (AD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-11-19
- Last Posted Date
- 2025-11-19
- Lead Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT07235384
- Locations
- 🇳🇿
ZaiLab Site 18001, Auckland, Auckland, New Zealand
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer
Not Applicable
Not yet recruiting
- Conditions
- Small-cell Lung Cancer
- Interventions
- Drug: ZL-1310 Dose Level 1Drug: ZL-1310 Dose Level 2Drug: Investigator's Choice of Therapy
- First Posted Date
- 2025-10-20
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Target Recruit Count
- 665
- Registration Number
- NCT07218146
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Thyroid Eye Disease (TED)
- Interventions
- Drug: ZL-1109 (VRDN-003)Drug: Placebo
- First Posted Date
- 2025-10-08
- Last Posted Date
- 2025-10-08
- Lead Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT07211776
- Locations
- 🇨🇳
Site01006, Beijing, China
🇨🇳Site01009, Beijing, China
🇨🇳Site01010, Beijing, China
A Study of ZL-1310 in Participants With Selected Solid Tumors
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT06885281
- Locations
- 🇺🇸
Zai Lab Site 2001, San Francisco, California, United States
🇺🇸Zai Lab Site 2002, New York, New York, United States
🇺🇸Zai Lab Site 2024, Cleveland, Ohio, United States
An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- First Posted Date
- 2023-12-21
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Target Recruit Count
- 85
- Registration Number
- NCT06179069
- Locations
- 🇪🇸
Zai Lab Site 8007, Barcelona, Spain
🇪🇸Zai Lab Site 8009, Madrid, Spain
🇪🇸Zai Lab Site 8008, Málaga, Spain
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found